SCHEMBL17008402

SCHEMBL17008402

C/C(=N\N(C)C)c1cccc(Br)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ F2RL1 P55085 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ C1S P09871 1/20 0.44
▸ PARP1 P09874 1/20 0.44
▸ MTOR P42345 3/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ALPG P10696 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8321303 0.79 NPC1 (0.54) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL7109724 0.79 NPC1 (0.54) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL17134067 0.79 NPC1 (0.54) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL14243296 0.78 CES2 (0.47) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19
SCHEMBL3725357 0.77 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL28127816 0.77 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL2615559 0.76 G6PC1 (0.57) NPC1RAB9ASMN1; SMN2CYP1A2L3MBTL1
SCHEMBL7373897 0.76 G6PC1 (0.57) NPC1RAB9ASMN1; SMN2CYP1A2L3MBTL1
SCHEMBL14667522 0.76 G6PC1 (0.57) NPC1RAB9ASMN1; SMN2CYP1A2L3MBTL1
SCHEMBL6815084 0.74 NPC1 (0.50) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3152211-A1 PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION ViiV Healthcare UK (No.5) Limited (GB) 2017-04-12 — — EP disclosed
WO-2015123182-A1 PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2015-08-20 — — WO disclosed
Send feedback